Welcome To IANS Live - SCIENCE-AND-TECHNOLOGY - US NIH to t

The Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.The

Related Keywords

New York , United States , Hugh Auchincloss , Us National Institutes Of Health , National Institute Of Allergy , Centers For Disease , National Institute , Infectious Disease , Disease Control , Vaccine , Influenza , Against , Seasonal , Participants , People , Universal , Safety , Vaccines , Receive ,